
Lan Coffman
Medical Oncology · University of Pittsburgh Physicians
Credentials: · · ·
History
- 2014–2016

- 2006–2010
Doctor of Medicine
Research
Serum ferritin: Past, present and future
Review · Biochimica et Biophysica Acta · 2010 · 626 citations
Review · Blood Reviews · 2009 · 461 citations
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
New England Journal of Medicine · 2023 · 405 citations

26 papers
- ST
10 papers

8 papers

7 papers · 7 as a resident

6 papers · 5 as a resident

6 papers · 5 as a fellow
- AO
5 papers

5 papers
Grants
- 2026–2031
Defining the Mechanism of Stromal Mediated Iron Dysregulation in Ovarian Clear Cell Cancer
National Cancer Institute · R01
Contact PI · $664.4K · University of Pittsburgh at Pittsburgh
- 2021–2027
Defining the Impact of Stromal Aging on Ovarian Cancer Initiation
National Institute on Aging · U01
Contact PI · $2.3M · University of Pittsburgh at Pittsburgh
- 2016–2022
National Cancer Institute · K08
Contact PI · $918.2K · University of Pittsburgh at Pittsburgh
Clinical trials
- 2024–2029
CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer
Principal investigator · Recruiting · Phase 1
Lan Coffman
- 2017–2022
Principal investigator · Completed · Phase 1
Ronald Buckanovich


